J Antimicrob Chemother. 1987 Jun;19(6):831-8.

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.

Jensen T, Pedersen SS, Garne S, Heilmann C, Høiby N, Koch C.

Abstract

Forty patients with cystic fibrosis and chronic broncho-pulmonary Pseudomonas aeruginosa infection entered a prospective double-blind placebo-controlled study of colistin inhalation. Active treatment consisted of inhalation of colistin one million units twice daily for three months and was compared to placebo inhalations of isotonic saline. Significantly more patients in the colistin inhalation group completed the study as compared to the placebo group (18 versus 11). Colistin treatment was superior to placebo treatment in terms of a significantly better clinical symptom score, maintenance of pulmonary function and inflammatory parameters. We recommend colistin inhalation therapy for cystic fibrosis patients with chronic P. aeruginosa lung infection as a supplementary treatment to frequent courses of intravenous anti-pseudomonas chemotherapy.

PMID:: 3301785; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

COLISTIN - HSDB

Supplemental Content

Related citations

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. [Pediatr Pulmonol. 1997]
Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.
Frederiksen B, Koch C, Høiby N. Pediatr Pulmonol. 1997 May; 23(5):330-5.
Review Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. [Drugs. 2003]
Review Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Cheer SM, Waugh J, Noble S. Drugs. 2003; 63(22):2501-20.
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. [Eur Respir J. 2002]
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.
Hodson ME, Gallagher CG, Govan JR. Eur Respir J. 2002 Sep; 20(3):658-64.
Review Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. [Clin Microbiol Infect. 2005]
Review Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, et al. Clin Microbiol Infect. 2005 Sep; 11(9):690-703.
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study. [Paediatr Drugs. 2007]
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
Chuchalin A, Csiszér E, Gyurkovics K, Bartnicka MT, Sands D, Kapranov N, Varoli G, Monici Preti PA, Mazurek H. Paediatr Drugs. 2007; 9 Suppl 1:21-31.

See reviews... See all...

Cited by 30 PubMed Central articles

The potential of antimicrobial peptides as biocides. [Int J Mol Sci. 2011]
The potential of antimicrobial peptides as biocides.
Laverty G, Gorman SP, Gilmore BF. Int J Mol Sci. 2011; 12(10):6566-96. Epub 2011 Oct 6.
Review Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. [BMC Med. 2011]
Review Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
Høiby N. BMC Med. 2011 Apr 4; 9:32. Epub 2011 Apr 4.
Review Clinical significance of microbial infection and adaptation in cystic fibrosis. [Clin Microbiol Rev. 2011]
Review Clinical significance of microbial infection and adaptation in cystic fibrosis.
Hauser AR, Jain M, Bar-Meir M, McColley SA. Clin Microbiol Rev. 2011 Jan; 24(1):29-70.

See all...

Chemical compound information

Colistin

MW: 1155.43 g/mol

MF: C₅₂H₉₈N₁₆O₁₃

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas...
Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
J Antimicrob Chemother. 1987 Jun ;19(6):831-8.

PubMed
Hypogammaglobulinemia in patients with cystic fibrosis.
Hypogammaglobulinemia in patients with cystic fibrosis.
N Engl J Med. 1980 Jan 31 ;302(5):245-9.

PubMed
Long-term treatment with beclomethasone dipropionate aerosol in asthmatic childr...
Long-term treatment with beclomethasone dipropionate aerosol in asthmatic children with special reference to growth.
Allergy. 1979 Feb ;34(1):57-61.

PubMed
Idiopathic inflammatory myopathies: current and future therapeutic options.
Idiopathic inflammatory myopathies: current and future therapeutic options.
Neurotherapeutics. 2008 Oct ;5(4):548-57.

PubMed
The nuclear vitamin D receptor controls the expression of genes encoding factors...
The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging.
J Steroid Biochem Mol Biol. 2010 Jul ;121(1-2):88-97. Epub 2010 Mar 20 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 30 PubMed Central articles

Chemical compound information

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information